Givaudan’s direct competitor, Symrise, presented terrific growth results this morning (05.05.2015). Quarterly turnover was 3.5% above market expectations and organic growth was at 6%. These figures are much better than those presented by Givaudan, whose shares are currently trading with a premium of around 15% (based on EV/EBITDA FY16), while organic growth is just on 1.1%.
The next share price impulse for Givaudan won’t occur until later this year (between September and November) when its strategic plans for 2020 will be unveiled.